Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Uche, Ifeanyi Kingsley
77  Ergebnisse:
Personensuche X
?
1

Targeting Cancers with oHSV-Based Oncolytic Viral Immunothe..:

Nasar, Rakin Tammam ; Uche, Ifeanyi Kingsley ; Kousoulas, Konstantin G.
Current Issues in Molecular Biology.  46 (2024)  6 - p. 5582-5594 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Utility of a Recombinant HSV-1 Vaccine Vector for Personali..:

Uche, Ifeanyi Kingsley ; Stanfield, Brent A. ; Rudd, Jared S...
Frontiers in Molecular Biosciences.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-La..:

Uche, Ifeanyi Kingsley ; Fowlkes, Natalie ; Vu, Luan...
Journal of Virology.  95 (2021)  3 - p. , 2021
Link: https://doi.org/10.1128/..
 
?
4

45724 VC2 Oncolytic Virotherapy Induces Robust Systemic Ant..:

Uche, Ifeanyi Kingsley ; Fowlkes, Natalie ; Vu, Luan...
Journal of Clinical and Translational Science.  5 (2021)  s1 - p. 13-14 , 2021
Link: https://doi.org/10.1017/..
 
?
5

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic..:

Uche, Ifeanyi Kingsley ; Kousoulas, Konstantin G. ; Rider, Paul J. F.
Viruses.  13 (2021)  7 - p. 1200 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Utility of a Recombinant HSV-1 Vaccine Vector for Personali..:

Uche, Ifeanyi Kingsley ; Stanfield, Brent A ; Rudd, Jared S..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826227/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic..:

Uche, Ifeanyi Kingsley ; Kousoulas, Konstantin G ; Rider, Paul J. F
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310320/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-La..:

Uche, Ifeanyi Kingsley ; Fowlkes, Natalie ; Vu, Luan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925097/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Utility of a Recombinant HSV-1 Vaccine Vector for Personali..:

Ifeanyi Kingsley Uche ; Brent A. Stanfield ; Jared S. Rudd..
https://www.frontiersin.org/articles/10.3389/fmolb.2022.832393/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
10

DataSheet1_Utility of a Recombinant HSV-1 Vaccine Vector fo..:

Ifeanyi Kingsley Uche ; Brent A. Stanfield ; Jared S. Rudd..
doi:10.3389/fmolb.2022.832393.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic..:

Ifeanyi Kingsley Uche ; Konstantin G. Kousoulas ; Paul J. F. Rider
https://www.mdpi.com/1999-4915/13/7/1200.  , 2021
Link: https://doi.org/10.3390/..
 
?
12

45724 VC2 Oncolytic Virotherapy Induces Robust Systemic Ant..:

Ifeanyi Kingsley Uche ; Natalie Fowlkes ; Luan Vu...
https://www.cambridge.org/core/product/identifier/S2059866121004374/type/journal_article.  , 2021
Link: https://doi.org/10.1017/..
 
?
13

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic..:

Ifeanyi Kingsley Uche ; Konstantin G. Kousoulas ; Paul J. F. Rider
Viral Immunology, Vaccines, and Antivirals.  , 2021
Link: https://doi.org/10.3390/..
 
?
14

The Risk of Islet Cell and Insulin Autoantibodies and Their..:

Adejumo, Babatunde Ishola ; Dimkpa, Uchechukwu ; Ewenighi, Chinwe Obianuju...
Health.  8 (2016)  12 - p. 1223-1233 , 2016
Link: https://doi.org/10.4236/..
 
?
15

DataSheet1_Utility of a Recombinant HSV-1 Vaccine Vector fo..:

Ifeanyi Kingsley Uche (12001088) ; Brent A. Stanfield (8415027) ; Jared S. Rudd (12001091)..
https://figshare.com/articles/dataset/DataSheet1_Utility_of_a_Recombinant_HSV-1_Vaccine_Vector_for_Personalized_Cancer_Vaccines_docx/19068845.  , 2022
Link: https://doi.org/10.3389/..
 
1-15